Ovarian Cancer
Clinical Trial Uses Bioactive Lipids As Diagnostic Blood Test
Published in Women's Health Weekly, August 30th, 2001
Ovarian cancer claims more lives in the U.S. than any other gynecologic malignancy, in part because there is currently no reliable diagnostic tool. The primary objective of the trial is to use Atairgin's lipid assay to confirm the presence of an ovarian malignancy in women with a suspicious pelvic mass. Atairgin expects to complete the sample testing and statistical analysis phases of the trial in the third quarter of 2001 and intends to submit the PMA (premarket...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Ovarian Cancer
Certain Symptoms Common in Affected Women - Pre-Eclampsia
Irregular Growth Factor Levels Mark Heightened Risk During Pregnancy - Adverse Drug Effects
Study Finds Third Generation Oral Contraceptive Increases Risk Of Blood Clots - Breast Cancer
New Method of Magnetic Resonance Imaging Distinguishes Benign from Malignant Breast Lesions - Diagnostics
Pap Tests On Women With Hysterectomies Cost Millions Of Dollars - Mental Health
Study Finds Depression More Common During Pregnancy Than After Childbirth - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
